FDA
-
-
-
-
-
-
-
Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance
-
-
-
-
-
-
-
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products
-
-
-
-
-
-
-
Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026
-
-
-
-
-
-
-
Picard Medical / SynCardia Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology
-
-
-
-
-
-
-
Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product
-
-
-
-
-
-
-
Picard Medical / SynCardia COO to Deliver Keynote at Venture Café Phoenix During Arizona Tech Week
-
326,851 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

